Fairmount Funds Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $24.3M | Hold |
|
|||||
|
2022
Q2 | $22.2M | Hold |
|
|||||
|
2022
Q1 | $33.4M | Buy |
|
|||||
|
2021
Q4 | $29M | Buy |
|
|||||
|
2021
Q3 | $18M | Buy |
|
|||||
|
2021
Q2 | $7.84M | Buy |
|
|||||
|
2021
Q1 | $8.44M | Buy |
|
|||||
|
2020
Q4 | $6.33M | Sell |
|
|||||
|
2020
Q3 | $7.43M | Sell |
|
|||||
|
2020
Q2 | $8.53M | Hold |
|
|||||
|
2020
Q1 | $8.74M | Buy |
|
|||||
|
2019
Q4 | $10M | Buy |
|